Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IDN6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 22 |
GO:0006259 | DNA metabolic process | 4 | 22 |
GO:0006281 | DNA repair | 5 | 22 |
GO:0006310 | DNA recombination | 5 | 22 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 22 |
GO:0006807 | nitrogen compound metabolic process | 2 | 22 |
GO:0006950 | response to stress | 2 | 22 |
GO:0006974 | DNA damage response | 4 | 22 |
GO:0008152 | metabolic process | 1 | 22 |
GO:0009987 | cellular process | 1 | 22 |
GO:0033554 | cellular response to stress | 3 | 22 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 22 |
GO:0043170 | macromolecule metabolic process | 3 | 22 |
GO:0044237 | cellular metabolic process | 2 | 22 |
GO:0044238 | primary metabolic process | 2 | 22 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 22 |
GO:0046483 | heterocycle metabolic process | 3 | 22 |
GO:0050896 | response to stimulus | 1 | 22 |
GO:0051716 | cellular response to stimulus | 2 | 22 |
GO:0071704 | organic substance metabolic process | 2 | 22 |
GO:0090304 | nucleic acid metabolic process | 4 | 22 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 22 |
GO:0003824 | catalytic activity | 1 | 22 |
GO:0003909 | DNA ligase activity | 4 | 22 |
GO:0003910 | DNA ligase (ATP) activity | 5 | 22 |
GO:0005488 | binding | 1 | 22 |
GO:0005524 | ATP binding | 5 | 22 |
GO:0016874 | ligase activity | 2 | 22 |
GO:0016886 | ligase activity, forming phosphoric ester bonds | 3 | 22 |
GO:0017076 | purine nucleotide binding | 4 | 22 |
GO:0030554 | adenyl nucleotide binding | 5 | 22 |
GO:0032553 | ribonucleotide binding | 3 | 22 |
GO:0032555 | purine ribonucleotide binding | 4 | 22 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 22 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 22 |
GO:0036094 | small molecule binding | 2 | 22 |
GO:0043167 | ion binding | 2 | 22 |
GO:0043168 | anion binding | 3 | 22 |
GO:0097159 | organic cyclic compound binding | 2 | 22 |
GO:0097367 | carbohydrate derivative binding | 2 | 22 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 22 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 22 |
GO:1901265 | nucleoside phosphate binding | 3 | 22 |
GO:1901363 | heterocyclic compound binding | 2 | 22 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 369 | 373 | PF00656 | 0.428 |
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.269 |
CLV_NRD_NRD_1 | 265 | 267 | PF00675 | 0.292 |
CLV_NRD_NRD_1 | 394 | 396 | PF00675 | 0.335 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.279 |
CLV_PCSK_KEX2_1 | 255 | 257 | PF00082 | 0.312 |
CLV_PCSK_KEX2_1 | 331 | 333 | PF00082 | 0.284 |
CLV_PCSK_KEX2_1 | 394 | 396 | PF00082 | 0.304 |
CLV_PCSK_KEX2_1 | 429 | 431 | PF00082 | 0.430 |
CLV_PCSK_PC1ET2_1 | 255 | 257 | PF00082 | 0.321 |
CLV_PCSK_PC1ET2_1 | 331 | 333 | PF00082 | 0.291 |
CLV_PCSK_PC1ET2_1 | 429 | 431 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.296 |
CLV_PCSK_SKI1_1 | 360 | 364 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 400 | 404 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.385 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.457 |
DEG_SIAH_1 | 293 | 301 | PF03145 | 0.384 |
DOC_CKS1_1 | 1 | 6 | PF01111 | 0.307 |
DOC_CKS1_1 | 376 | 381 | PF01111 | 0.256 |
DOC_MAPK_gen_1 | 48 | 55 | PF00069 | 0.645 |
DOC_PP1_RVXF_1 | 145 | 152 | PF00149 | 0.388 |
DOC_PP1_RVXF_1 | 346 | 353 | PF00149 | 0.391 |
DOC_PP1_RVXF_1 | 79 | 86 | PF00149 | 0.533 |
DOC_PP2B_LxvP_1 | 185 | 188 | PF13499 | 0.307 |
DOC_PP4_FxxP_1 | 376 | 379 | PF00568 | 0.421 |
DOC_PP4_FxxP_1 | 85 | 88 | PF00568 | 0.524 |
DOC_USP7_MATH_1 | 380 | 384 | PF00917 | 0.455 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.218 |
DOC_USP7_UBL2_3 | 381 | 385 | PF12436 | 0.421 |
DOC_WW_Pin1_4 | 127 | 132 | PF00397 | 0.308 |
DOC_WW_Pin1_4 | 375 | 380 | PF00397 | 0.340 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.585 |
DOC_WW_Pin1_4 | 5 | 10 | PF00397 | 0.328 |
LIG_14-3-3_CanoR_1 | 18 | 26 | PF00244 | 0.307 |
LIG_14-3-3_CanoR_1 | 271 | 277 | PF00244 | 0.468 |
LIG_Actin_WH2_2 | 132 | 149 | PF00022 | 0.226 |
LIG_BRCT_BRCA1_1 | 234 | 238 | PF00533 | 0.373 |
LIG_BRCT_BRCA1_1 | 311 | 315 | PF00533 | 0.351 |
LIG_BRCT_BRCA1_1 | 81 | 85 | PF00533 | 0.522 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.373 |
LIG_FHA_2 | 118 | 124 | PF00498 | 0.272 |
LIG_FHA_2 | 367 | 373 | PF00498 | 0.413 |
LIG_LIR_Apic_2 | 82 | 88 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 189 | 199 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 239 | 250 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 25 | 34 | PF02991 | 0.272 |
LIG_LIR_Gen_1 | 403 | 414 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 189 | 195 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 219 | 223 | PF02991 | 0.269 |
LIG_LIR_Nem_3 | 239 | 245 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 312 | 318 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 333 | 337 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 344 | 350 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 403 | 409 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 78 | 83 | PF02991 | 0.402 |
LIG_MYND_1 | 167 | 171 | PF01753 | 0.307 |
LIG_PCNA_PIPBox_1 | 214 | 223 | PF02747 | 0.307 |
LIG_PCNA_yPIPBox_3 | 209 | 221 | PF02747 | 0.318 |
LIG_PDZ_Class_3 | 428 | 433 | PF00595 | 0.502 |
LIG_PDZ_Wminus1_1 | 431 | 433 | PF00595 | 0.478 |
LIG_REV1ctd_RIR_1 | 149 | 158 | PF16727 | 0.324 |
LIG_SH2_CRK | 242 | 246 | PF00017 | 0.291 |
LIG_SH2_CRK | 291 | 295 | PF00017 | 0.369 |
LIG_SH2_CRK | 80 | 84 | PF00017 | 0.402 |
LIG_SH2_SRC | 327 | 330 | PF00017 | 0.267 |
LIG_SH2_STAP1 | 227 | 231 | PF00017 | 0.335 |
LIG_SH2_STAT3 | 227 | 230 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.307 |
LIG_SH2_STAT5 | 260 | 263 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 397 | 400 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 401 | 404 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.575 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.296 |
LIG_SH3_3 | 320 | 326 | PF00018 | 0.307 |
LIG_SH3_3 | 412 | 418 | PF00018 | 0.296 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.557 |
LIG_SUMO_SIM_par_1 | 176 | 182 | PF11976 | 0.350 |
LIG_TYR_ITIM | 404 | 409 | PF00017 | 0.313 |
LIG_UBA3_1 | 169 | 175 | PF00899 | 0.428 |
LIG_UBA3_1 | 319 | 324 | PF00899 | 0.272 |
MOD_CDC14_SPxK_1 | 45 | 48 | PF00782 | 0.377 |
MOD_CDK_SPK_2 | 127 | 132 | PF00069 | 0.296 |
MOD_CDK_SPxK_1 | 375 | 381 | PF00069 | 0.323 |
MOD_CDK_SPxK_1 | 42 | 48 | PF00069 | 0.370 |
MOD_CDK_SPxxK_3 | 42 | 49 | PF00069 | 0.375 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.150 |
MOD_CK1_1 | 232 | 238 | PF00069 | 0.338 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.373 |
MOD_CK2_1 | 111 | 117 | PF00069 | 0.395 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.334 |
MOD_Cter_Amidation | 329 | 332 | PF01082 | 0.291 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.269 |
MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.338 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.376 |
MOD_GlcNHglycan | 360 | 363 | PF01048 | 0.410 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.413 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.291 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.545 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.384 |
MOD_N-GLC_1 | 51 | 56 | PF02516 | 0.584 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.233 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.447 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.478 |
MOD_NEK2_2 | 380 | 385 | PF00069 | 0.475 |
MOD_PIKK_1 | 309 | 315 | PF00454 | 0.326 |
MOD_PIKK_1 | 408 | 414 | PF00454 | 0.323 |
MOD_PKA_1 | 255 | 261 | PF00069 | 0.326 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.298 |
MOD_PKA_2 | 255 | 261 | PF00069 | 0.326 |
MOD_PKA_2 | 270 | 276 | PF00069 | 0.326 |
MOD_PKA_2 | 423 | 429 | PF00069 | 0.506 |
MOD_Plk_1 | 51 | 57 | PF00069 | 0.638 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.349 |
MOD_ProDKin_1 | 127 | 133 | PF00069 | 0.308 |
MOD_ProDKin_1 | 375 | 381 | PF00069 | 0.340 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.594 |
MOD_ProDKin_1 | 5 | 11 | PF00069 | 0.328 |
MOD_SUMO_rev_2 | 206 | 211 | PF00179 | 0.410 |
MOD_SUMO_rev_2 | 344 | 350 | PF00179 | 0.496 |
TRG_DiLeu_BaEn_1 | 240 | 245 | PF01217 | 0.291 |
TRG_DiLeu_BaLyEn_6 | 213 | 218 | PF01217 | 0.428 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.296 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.313 |
TRG_ENDOCYTIC_2 | 339 | 342 | PF00928 | 0.382 |
TRG_ENDOCYTIC_2 | 401 | 404 | PF00928 | 0.307 |
TRG_ENDOCYTIC_2 | 406 | 409 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.405 |
TRG_ER_diArg_1 | 199 | 201 | PF00400 | 0.291 |
TRG_NLS_Bipartite_1 | 255 | 270 | PF00514 | 0.368 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAX3 | Leptomonas seymouri | 78% | 87% |
A0A0S4IPC3 | Bodo saltans | 26% | 100% |
A0A0S4KIC5 | Bodo saltans | 33% | 76% |
A0A0S4KP75 | Bodo saltans | 35% | 95% |
A0A1X0NS61 | Trypanosomatidae | 33% | 83% |
A0A1X0NSF5 | Trypanosomatidae | 60% | 83% |
A0A3Q8IDV4 | Leishmania donovani | 25% | 69% |
A0A3S5IR98 | Trypanosoma rangeli | 35% | 89% |
A0A422NIS8 | Trypanosoma rangeli | 56% | 100% |
A4HEY9 | Leishmania braziliensis | 27% | 100% |
A4HEZ0 | Leishmania braziliensis | 89% | 100% |
A4I263 | Leishmania infantum | 26% | 100% |
A4I264 | Leishmania infantum | 100% | 100% |
C9ZRT4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 85% |
C9ZRT5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 90% |
E9AYB3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 69% |
E9AYB4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q959 | Leishmania major | 96% | 100% |
V5AUB9 | Trypanosoma cruzi | 60% | 83% |
V5DAB4 | Trypanosoma cruzi | 35% | 89% |